Plain-English translation of NCT07527715 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether a special type of heart imaging called cardiac magnetic resonance (CMR) can help doctors predict which patients with dilated cardiomyopathy—a condition where the heart's main pumping chamber becomes enlarged and weakened—are most at risk for serious problems like heart failure, dangerous heart rhythms, or death. The imaging takes detailed pictures of your heart while it's under mild stress, similar to light exercise, to see how well blood flows through the heart muscle. Researchers will combine this imaging data with your other medical information to create a prediction tool that can identify high-risk patients early.
Right now, doctors struggle to predict which patients with enlarged hearts will have the worst outcomes, making it hard to give the right care to those who need it most. This study aims to solve that problem by developing a better tool to spot high-risk patients earlier, so they can get targeted treatment and closer monitoring.
You likely qualify if…
You likely don't qualify if…
You will undergo a cardiac magnetic resonance (CMR) imaging scan, which is a safe, non-invasive test that takes detailed pictures of your heart. During the scan, your heart will be mildly stressed—usually by receiving medication that increases your heart rate slightly, similar to light exercise—so doctors can see how your heart performs under mild workload. Researchers will collect this imaging data along with your other medical information to help build and test the prediction model.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China